New Directions in Infection-Associated Ischemic Stroke
Copyright © 2024 Korean Neurological Association..
The relationship between infections and stroke has not been fully characterized, probably delaying the development of specific treatments. This narrative review addresses mechanisms of stroke linked to infections, including hypercoagulability, endothelial dysfunction, vasculitis, and impaired thrombolysis. SARS-CoV-2, the virus that causes COVID-19, may promote the development of stroke, which may represent its most severe neurological complication. The development of specific therapies for infection-associated stroke remains a profound challenge. Perhaps the most important remaining issue is the distinction between infections that trigger a stroke versus infections that are truly incidental. This distinction likely requires the establishment of appropriate biomarkers, candidates of which are elevated levels of fibrin D-dimer and anticardiolipin/antiphospholipid antibodies. These candidate biomarkers might have potential use in identifying pathogenic infections preceding stroke, which is a precursor to establishing specific therapies for this syndrome.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
|---|---|
| Enthalten in: |
Journal of clinical neurology (Seoul, Korea) - 20(2024), 2 vom: 02. März, Seite 140-152 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Jung, Jin-Man [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Anticardiolipin/antiphospholipid antibodies |
|---|
| Anmerkungen: |
Date Revised 10.03.2024 published: Print-Electronic Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.3988/jcn.2023.0056 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368199045 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368199045 | ||
| 003 | DE-627 | ||
| 005 | 20240310231937.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240209s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3988/jcn.2023.0056 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1322.xml |
| 035 | |a (DE-627)NLM368199045 | ||
| 035 | |a (NLM)38330416 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Jung, Jin-Man |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a New Directions in Infection-Associated Ischemic Stroke |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 10.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a Copyright © 2024 Korean Neurological Association. | ||
| 520 | |a The relationship between infections and stroke has not been fully characterized, probably delaying the development of specific treatments. This narrative review addresses mechanisms of stroke linked to infections, including hypercoagulability, endothelial dysfunction, vasculitis, and impaired thrombolysis. SARS-CoV-2, the virus that causes COVID-19, may promote the development of stroke, which may represent its most severe neurological complication. The development of specific therapies for infection-associated stroke remains a profound challenge. Perhaps the most important remaining issue is the distinction between infections that trigger a stroke versus infections that are truly incidental. This distinction likely requires the establishment of appropriate biomarkers, candidates of which are elevated levels of fibrin D-dimer and anticardiolipin/antiphospholipid antibodies. These candidate biomarkers might have potential use in identifying pathogenic infections preceding stroke, which is a precursor to establishing specific therapies for this syndrome | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a anticardiolipin/antiphospholipid antibodies | |
| 650 | 4 | |a fibrin D-dimer | |
| 650 | 4 | |a infections | |
| 650 | 4 | |a stroke | |
| 650 | 4 | |a thrombosis | |
| 700 | 1 | |a Gruber, András |e verfasserin |4 aut | |
| 700 | 1 | |a Heseltine, Peter |e verfasserin |4 aut | |
| 700 | 1 | |a Rajamani, Kumar |e verfasserin |4 aut | |
| 700 | 1 | |a Ameriso, Sebastián F |e verfasserin |4 aut | |
| 700 | 1 | |a Fisher, Mark J |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of clinical neurology (Seoul, Korea) |d 2005 |g 20(2024), 2 vom: 02. März, Seite 140-152 |w (DE-627)NLM189162376 |x 1738-6586 |7 nnns |
| 773 | 1 | 8 | |g volume:20 |g year:2024 |g number:2 |g day:02 |g month:03 |g pages:140-152 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3988/jcn.2023.0056 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 20 |j 2024 |e 2 |b 02 |c 03 |h 140-152 | ||